Home/Investors/Northpond Ventures

Northpond Ventures

Biotech Investor · 7 portfolio companies

Portfolio

7

Combined Value

$98K

Focus Areas

18

Top Stage

preclinical

Investment Focus

Antibody Discovery Cell & Gene Therapy Vaccine Development Genetics & Genomics Rare Disease Musculoskeletal Rheumatoid Arthritis Autoimmune Diseases Inflammatory Bowel Disease Infectious Disease Oncology Neurology Cardiovascular Metabolic Genetic Disorders

Portfolio Companies

Company	Stage	Valuation	Focus
Telesis Bio	—	$98K	Antibody Discovery, Cell & Gene Therapy
Aro Biotherapeutics	preclinical	—	Genetics & Genomics, Rare Disease
Kytopen	Pre-clinical	—	Cell & Gene Therapy
Scipher Medicine	Commercial	—	Rheumatoid Arthritis, Autoimmune Diseases
Sherlock Biosciences	Pre-clinical	—	Infectious Disease, Oncology
StrideBio	Phase 1	—	Neurology, Cardiovascular
Garuda Therapeutics	preclinical	—	Hematology, Cell Therapy

Frequent Co-Investors

Johnson & Johnson Innovation1 shared Claris Ventures1 shared Alexandria Venture Investments1 shared HealthCap1 shared BVF Partners1 shared Baidu Ventures1 shared Novartis Venture Fund1 shared Khosla Ventures1 shared